Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP & Chief Commercial Officer | February 17, 2021 | February 22, 2021 |
| Quotient LtdQTNT · Entity 116378 | Director · Chief Executive Officer | June 24, 2022 | June 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date February 17, 2021 · Filed February 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,045 |
Reported balance
After 2021-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-02-17 · Grant · Acquired 4,926 · Balance 29,045 F1: Represents an award of restricted share units. F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| Non-Qualifed Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $121.81 · Expires 2031-02-17 | Direct | 27,633 |
Reported balance
After 2021-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-17 · Grant · Acquired 27,633 · Balance 27,633 F3: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted share units.
F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
F3: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Quotient Ltd
Report date June 24, 2022 · Filed June 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 483,333 |
Reported balance
After 2022-06-24 transaction · row 1
1 source rowRow 1 · 2022-06-24 · Purchase · Acquired 66,666 · Balance 483,333 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 471,014 |
Reported balance
Holding disclosure · report date 2022-06-24 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 471,014 F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F2: 416,667 restricted stock units have vested and converted into ordinary shares. The remaining 471,014 restricted stock units will vest in two equal installments on April 1, 2023 and April 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 500,000 |
Reported balance
Holding disclosure · report date 2022-06-24 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 500,000 F4: On April 1, 2022, the Reporting Person was granted 500,000 restricted stock units, vesting in three equal annual installments beginning April 1, 2023. Upon vesting, the restricted stock units will either convert into ordinary shares on a one-for-one basis or will be settled in cash on the vesting date in an amount equal to the fair market value of an ordinary share on such date, as determined by the Company. |
| Ordinary Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.68 · Expires 2031-04-01 | Direct | 718,788 |
Reported balance
Holding disclosure · report date 2022-06-24 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 718,788 F3: 239,595 options vested on April 1, 2022 and remain exercisable, and the remaining 479,193 options will vest in two equal installments on April 1, 2023 and April 1, 2024. |
| Ordinary Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2032-04-01 | Direct | 504,882 |
Reported balance
Holding disclosure · report date 2022-06-24 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 504,882 F5: The options vest and become exercisable in three equal annual installments beginning April 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis.
F2: 416,667 restricted stock units have vested and converted into ordinary shares. The remaining 471,014 restricted stock units will vest in two equal installments on April 1, 2023 and April 1, 2024.
F3: 239,595 options vested on April 1, 2022 and remain exercisable, and the remaining 479,193 options will vest in two equal installments on April 1, 2023 and April 1, 2024.
F4: On April 1, 2022, the Reporting Person was granted 500,000 restricted stock units, vesting in three equal annual installments beginning April 1, 2023. Upon vesting, the restricted stock units will either convert into ordinary shares on a one-for-one basis or will be settled in cash on the vesting date in an amount equal to the fair market value of an ordinary share on such date, as determined by the Company.
F5: The options vest and become exercisable in three equal annual installments beginning April 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2022 Filed Jun 28, 2022 17:51 UTC | Quotient Ltd QTNT · Entity 116378 | PurchaseOrdinary Shares | 66,666 | $0.30 | $19,999.80 |
DisclosureSEC source: 0000899243-22-024430 · doc4.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,333 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 504,882 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000899243-22-013784 · doc4.xml · derivative · entry 5 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,882 Underlying: Ordinary Shares · 504,882 shares Expires 2032-04-01 F5 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments beginning April 1, 2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013784 · doc4.xml · derivative · entry 4 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Ordinary Shares · 500,000 shares Expires not disclosed F4 · derivative.exercise_price: On April 1, 2022, the Reporting Person was granted 500,000 restricted stock units, vesting in three equal annual installments beginning April 1, 2023. Upon vesting, the restricted stock units will either convert into ordinary shares on a one-for-one basis or will be settled in cash on the vesting date in an amount equal to the fair market value of an ordinary share on such date, as determined by the Company. F4 · derivative.exercise_date: On April 1, 2022, the Reporting Person was granted 500,000 restricted stock units, vesting in three equal annual installments beginning April 1, 2023. Upon vesting, the restricted stock units will either convert into ordinary shares on a one-for-one basis or will be settled in cash on the vesting date in an amount equal to the fair market value of an ordinary share on such date, as determined by the Company. F4 · derivative.expiration_date: On April 1, 2022, the Reporting Person was granted 500,000 restricted stock units, vesting in three equal annual installments beginning April 1, 2023. Upon vesting, the restricted stock units will either convert into ordinary shares on a one-for-one basis or will be settled in cash on the vesting date in an amount equal to the fair market value of an ordinary share on such date, as determined by the Company. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | Disposition to issuerRestricted Stock Units · Derivative | 416,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013784 · doc4.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,014 Underlying: Ordinary Shares · 416,667 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F2 · derivative.exercise_date: 416,667 restricted stock units have vested and converted into ordinary shares. The remaining 471,014 restricted stock units will vest in two equal installments on April 1, 2023 and April 1, 2024. F2 · derivative.expiration_date: 416,667 restricted stock units have vested and converted into ordinary shares. The remaining 471,014 restricted stock units will vest in two equal installments on April 1, 2023 and April 1, 2024. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionOrdinary Shares | 416,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013784 · doc4.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 17:41 UTC | Quotient Ltd QTNT · Entity 116378 | Disposition to issuerOrdinary Share Option (Right to Buy) · Derivative | 138,227 | $2.41 Strike: $3.68 | $333,127.07 |
DisclosureSEC source: 0000899243-21-040634 · doc4.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,788 Underlying: Ordinary Shares · 138,227 shares Expires 2031-04-01 F3 · derivative.exercise_date: The reporting person and Quotient Ltd. mutually agreed to cancel 181,159 RSUs and 138,227 options and in lieu thereof to pay to the reporting person $1,000,000 in cash, net of social security and tax cost deductions, to support the reporting person's relocation to Switzerland where Quotient Ltd.'s principal executive offices are located. The remaining options will vest in three equal annual installments beginning on April 1, 2022. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 17:41 UTC | Quotient Ltd QTNT · Entity 116378 | Disposition to issuerRestricted Stock Units · Derivative | 181,159 | $3.68 | $666,665.12 |
DisclosureSEC source: 0000899243-21-040634 · doc4.xml · derivative · entry 1 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,681 Underlying: Ordinary Shares · 181,159 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F2 · derivative.exercise_date: The reporting person and Quotient Ltd. mutually agreed to cancel 181,159 Restricted Stock Units (RSUs) and 138,227 options and in lieu thereof to pay to the reporting person $1,000,000 in cash, net of social security and tax cost deductions, to support the reporting person's relocation to Switzerland where Quotient Ltd.'s principal executive offices are located. Of the remaining RSUs,163,043 will vest in three equal annual installments beginning April 1, 2022, and the balance will vest over three years with 50% vesting on April 1, 2022 and the balance vesting proportionately over the remaining two years. F2 · derivative.expiration_date: The reporting person and Quotient Ltd. mutually agreed to cancel 181,159 Restricted Stock Units (RSUs) and 138,227 options and in lieu thereof to pay to the reporting person $1,000,000 in cash, net of social security and tax cost deductions, to support the reporting person's relocation to Switzerland where Quotient Ltd.'s principal executive offices are located. Of the remaining RSUs,163,043 will vest in three equal annual installments beginning April 1, 2022, and the balance will vest over three years with 50% vesting on April 1, 2022 and the balance vesting proportionately over the remaining two years. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 165,874 | $0.00 Strike: $3.68 | $0.00 |
DisclosureSEC source: 0000899243-21-014870 · doc4.xml · derivative · entry 4 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,874 Underlying: Ordinary Shares · 165,874 shares Expires 2031-04-01 F5 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments beginning April 1, 2022. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 691,141 | $0.00 Strike: $3.68 | $0.00 |
DisclosureSEC source: 0000899243-21-014870 · doc4.xml · derivative · entry 3 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691,141 Underlying: Ordinary Shares · 691,141 shares Expires 2031-04-01 F4 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments beginning April 1, 2022. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 163,043 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014870 · doc4.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,043 Underlying: Ordinary Shares · 163,043 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F3 · derivative.exercise_date: On April 1, 2021, the Reporting Person was granted 163,043 Restricted Stock Units, which will vest in three equal annual installments beginning April 1, 2022. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). F3 · derivative.expiration_date: On April 1, 2021, the Reporting Person was granted 163,043 Restricted Stock Units, which will vest in three equal annual installments beginning April 1, 2022. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 905,797 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014870 · doc4.xml · derivative · entry 1 Mendez Manuel O. · CIK 0001475995 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 905,797 Underlying: Ordinary Shares · 905,797 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F2 · derivative.exercise_date: On April 1, 2021, the Reporting Person was granted 905,797 Restricted Stock Units. The Restricted Stock Units will vest in three years, with 50% vesting on the first anniversary of the date of grant, and 25% vesting on each of the second and third anniversaries of the date of grant. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). F2 · derivative.expiration_date: On April 1, 2021, the Reporting Person was granted 905,797 Restricted Stock Units. The Restricted Stock Units will vest in three years, with 50% vesting on the first anniversary of the date of grant, and 25% vesting on each of the second and third anniversaries of the date of grant. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). Read SEC document |
| February 17, 2021 Filed Feb 22, 2021 21:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 27,633 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000030 · wf-form4_161403060246936.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,633 Underlying: Common Stock · 27,633 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 22, 2021 21:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000030 · wf-form4_161403060246936.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,045 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 06, 2020 Filed Oct 7, 2020 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,871 | $114.01 | $669,352.71 |
DisclosureSEC source: 0001022079-20-000171 · wf-form4_160210293696290.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,982 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 123 | $112.17 | $13,796.91 |
DisclosureSEC source: 0001022079-20-000043 · wf-form4_158275261294344.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,853 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 34,887 | $0.00 Strike: $112.17 | $0.00 |
DisclosureSEC source: 0001022079-20-000029 · wf-form4_158224883793698.xml · derivative · entry 2 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,887 Underlying: Common Stock · 34,887 shares Expires 2030-02-18 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000029 · wf-form4_158224883793698.xml · nonDerivative · entry 1 Mendez Manuel O. · CIK 0001475995 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,976 F1 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.